A Randomized, Open-label, Muti-centre, Phase IV Clinical Trial of Peg-IFN alfa-2b monotherapy or combined with Adefovir Dipivoxil for HBeAg positive Chronic Hepatitis B

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2012
This article has no abstract
Epistemonikos ID: 27eed488424616d054f64067f3330cf75808e442
First added on: Apr 16, 2025